Altheus Therapeutics, Inc., announced that it has completed enrollment for ZA201, a 6-week, double-blind, active-controlled Phase 2 clinical trial of the efficacy and safety of Zoenasa® Rectal Gel in approximately 120 adult patients ...
Tags: Altheus Therapeutics, enrollment, ZA201, Zoenasa®Rectal Gel
BASF is globally launching a new ultra-high molecular weight cationic powder flocculant range with Zetag ULTRA for solid/liquid separation in industrial and municipal waste water treatment. Zetag ULTRA has been developed combining ...
Tags: waste water treatment, sustainable natural resource management
Scientists have made an important advance in understanding how a subset of bacterial cells escape being killed by many antibiotics. Cells become "persisters" by entering a state in which they stop replicating and are able to tolerate ...
Tags: bacterial cells, antibiotics, antibiotic resistance, persister cells
Findings of a preliminary study published in The Lancet Respiratory Medicine suggest that a patient's own bone-marrow stromal (stem) cells could be used to treat multidrug-resistant (MDR) and extensively-drug (XDR) tuberculosis (TB). ...
Tags: bone-marrow stromal cells, multidrug-resistant tuberculosis
One way to win the predictions game is to make a lot of guesses and remember just the winners. Here at IEEE Spectrum, we play a harder game. We told you what to expect in 2013, and now we are 'fessing up to our misses, as well as bragging ...
Tags: Postmortem, IEEE Spectrum
A molecule nobody thought to explore may unlock a potential therapeutic target for a debilitating connective tissue disorder, according to Western-led research. Western professor Dr. David O'Gorman and PhD student Christina Raykha have ...
Tags: therapeutic target, connective tissue disorder, Dupuytren's disease
K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced it has received 510(k) ...
Tags: K2M, CAYMAN Minimally Invasive, CAYMAN Plate System, 510(k)clearance
A patient's own bone marrow stem cells might someday be used to treat multidrug-resistant tuberculosis, a new study suggests. The phase 1 study to assess the safety of the treatment included 30 patients, aged 21 to 65, with ...
U.S. government officials say under the Affordable Care Act most health insurance companies will cover drugs that help prevent breast cancer for free. Kathleen Sebelius, secretary for the U.S. Department of Health and Human Services, and ...
The drugs Mekinist and Tafinlar were approved for combination treatment of advanced melanoma skin cancer, the U.S. Food and Drug Administration announced Friday. The two medicines "are the first drugs approved for combination treatment of ...
Tags: FDA, 2-Drug Combo Treatment, Combo Treatment for Advanced Melanoma
Women who completed therapy experienced significant improvement in urinary incontinence, defecatory dysfunction and pelvic pain One in three women suffer from pelvic floor dysfunction (PFD), a range of symptoms which include bladder and ...
Tags: Health, Medicine, Pelvic Floor Dysfunction
Cardiovascular comorbidities may be going under-recognized and undertreated in patients with bipolar disorder, say UK researchers. This is despite the UK having a healthcare system that is free at the point of access, they note. "This ...
Sunesis Pharmaceuticals has expanded its hematology franchise through separate global licensing agreements for two preclinical kinase inhibitor programs. The first agreement, with Biogen Idec, is for global commercial rights to SNS-062, a ...
Tags: Sunesis Pharmaceuticals, Medicine
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) use of Mekinist (trametinib) in combination with Tafinlar (dabrafenib) for the treatment of patients with unresectable melanoma or metastatic melanoma with BRAF ...
Tags: FDA, Combination Drug
The National Pork Producers Council applauded today's introduction of congressional legislation to grant President Obama Trade Promotion Authority (TPA) as a means to conclude a successful Pacific Rim trade deal. The Obama administration ...